Panacea gains on DCGI nod for Sputnik V
Panacea Biotec has received a licence from the Drugs Controller General of India (DCGI) to manufacture Sputnik V, a development that saw the shares of
Admin
0
4
Panacea Biotec has received a licence from the Drugs Controller General of India (DCGI) to manufacture Sputnik V, a development that saw the shares of
